The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal

Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

Giovanni Parmigiani, Donald A. Berry, Omar Aguilar · The American Journal of Human Genetics · 1998 · 760 citations

Life Sciences, Genetics, Oncology +11

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

Anne Petrij-Bosch, Tamara Peelen, Margreethe van Vliet et al. · Nature Genetics · 1997 · 446 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

A high proportion of founder <i>BRCA1</i> mutations in Polish breast cancer families

Bohdan Górski, Anna Jakubowska, Tomasz Huzarski et al. · International Journal of Cancer · 2004 · 195 citations

Medicine, Genetics, Molecular Genetics +12

Analysis of<i>BRCA1</i>and<i>BRCA2</i>genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

Ana Osório, M. Durán, José I. Martínez‐Ferrandis et al. · Human Mutation · 2003 · 171 citations

Medicine, Genetics, Oncology +14

Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families

Patricia N. Tonin, Anne‐Marie Mes‐Masson, P. Andrew Futreal et al. · The American Journal of Human Genetics · 1998 · 170 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15